doi:10.19982/j.issn.1000-6621.20240597

Abstract

CLC Number:

R52
R524

Figures/Tables 4

References 11

[1]	Choudhury A, Dhillon J, Sekar A, et al. Differentiating gastrointestinal tuberculosis and Crohn’s disease-a comprehensive review. BMC Gastroenterol, 2023, 23(1):246. doi:10.1186/s12876-023-02887-0. pmid: 37468869
[2]	Seth R, Gupta P, Debi U, et al. Perfusion Computed Tomography May Help in Discriminating Gastrointestinal Tuberculosis and Crohn’s Disease. Diagnostics (Basel), 2023, 13(7):1255. doi:10.3390/diagnostics13071255.
[3]	Dolinger M, Torres J, Vermeire S. Crohn’s disease. Lancet, 2024, 403(10432):1177-1191. doi:10.1016/S0140-6736(23)02586-2. pmid: 38437854
[4]	Roda G, Chien Ng S, Kotze PG, et al. Crohn’s disease. Nat Rev Dis Primers, 2020, 6(1):22. doi:10.1038/s41572-020-0156-2.
[5]	杨格日乐, 李艳梅, 赵丽萍. 消化道结核临床及内镜特征研究进展. 中国防痨杂志, 2022, 44(5):517-521. doi:10.19982/j.issn.1000-6621.20210729.
[6]	Mandavdhare HS, Singh H, Dutta U, et al. A real-world experience with 6 months of antitubercular therapy in abdominal tuberculosis. JGH Open, 2019, 3(3):201-205. doi:10.1002/jgh3.12136. pmid: 31276036
[7]	Sharma V, Mandavdhare HS, Lamoria S, et al. Serial C-reactive protein measurements in patients treated for suspected abdominal tuberculosis. Dig Liver Dis, 2018, 50(6):559-562. doi:10.1016/j.dld.2017.12.008.
[8]	Phetsuksiri B, Rudeeaneksin J, Srisungngam S, et al. Comparison of Loop-Mediated Isothermal Amplification, Microscopy, Culture, and PCR for Diagnosis of Pulmonary Tuberculosis. Jpn J Infect Dis, 2020, 73(4):272-277. doi:10.7883/yoken.JJID.2019.335. pmid: 32115540
[9]	张帆, 刘守江, 魏巍, 等. 结核分枝杆菌实验室检测方法的结果差异分析及临床诊断评估. 实用预防医学, 2019, 26(8):1010-1012. doi:10.3969/j.issn.1006-3110.2019.08.033.
[10]	De Vito A, Fiore V, Urru V, et al. Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report. Braz J Infect Dis, 2022, 26(5):102701. doi:10.1016/j.bjid.2022.102701.
[11]	姚利, 刘小玉, 蒋钰辉, 等. 一例耐多药肠结核合并肠梗阻的手术治疗. 中国防痨杂志, 2023, 45(2):222-224. doi:10.19982/j.issn.1000-6621.20220450.

[1]	Yao Xiuyu, Du Ying, Chen Sijie, Geng Hong, Gao Lei. Common nursing problems and countermeasures or suggestions for home isolation and treatment of patients with infectious pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 681-686.
[2]	Ou Xichao, Teng Chong, Song Yuanyuan, Zheng Yang, Chen Lei, Zhu Jun, Wang Jianguo, Pan Zhaobao, Kang Haitao, Wang Yan, Yao Hongyan, Huang Fei. Multicenter evaluation study on the application of a novel PCR fluorescence probe technology for early diagnosis of tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 687-693.
[3]	Xie Zhongyao, Zhang Muli, Cao Tingming, Cao Yang, Sun Zhaogang. Research on the diagnostic value of specific ligand protein SMAD2-based detection method for active tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 694-700.
[4]	Zhao Yanfeng, Tu Xia, Wang Nenhan, Chen Shuangshuang, Tian Lili, Fan Ruifang, Yu Lan, Li Jie, Li Chuanyou, Dai Xiaowei. Contribution analysis of three diagnostic methods in the etiological detection of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 701-707.
[5]	Li Xuelian, Zhu Qingdong, Ma Yijing, Tusongjiang Maituoheti, Miriguli Maituoheti, Wang Qingfeng, Ma Liping, Chu Naihui, Nie Wenjuan, Lin Yanrong, Li Wei, Wang Jing. Analysis of incidence and risk factors for linezolid-related hematological side effects: a multicenter cohort study [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 719-726.
[6]	Peng Hua, Cui Junwei, Shang Qiubai, Li Siqing, Peng Ruiqin. Effectiveness of a nursing intervention based on the Transtheoretical Model combined with the Health Belief Model in patients with pulmonary tuberculosis and chronic obstructive pulmonary disease [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 727-731.
[7]	Wang Hanfei, Li Jinhao, Wen Yaxin, Xu Caihong. Analysis of diagnosis and treatment delays and influencing factors of rifampicin-resistant tuberculosis patients in China, 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 738-745.
[8]	Shi Xiaojing, Guo Jianhua, Wang Xin, Zhao Qingran, Wang Yuhan. A study on the acceptance of preventive treatment and its influencing factors among latent tuberculosis infectors in Shijiazhuang City [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 746-752.
[9]	Zhang Manhui, Zhang Mengdi, Lu Zheng, Li Junqi, Zheng Wenjing, Wang Xin, Huang Fei, Liu Jianjun, Yao Hongyan, Wang Qiqi. Analysis on the trends of pulmonary tuberculosis disease burden among the elderly population in China from 2005 to 2020 [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 753-759.
[10]	Li Yuhong, Mei Jinzhou, Li Xue, Zhang Hui, Liu Xiaoqiu, Zhao Yanlin. Analysis of the epidemiological characteristics of inter-provincial migrant tuberculosis patients from 2018 to 2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 760-768.
[11]	Shi Jie, Chang Wenjing, Zheng Danwei, Su Ruyue, Ma Xiaoguang, Zhu Yankun, Wang Shaohua, Sun Jianwei, Sun Dingyong. Screening of core genes and pathways involved in tuberculosis onset based on GEO database [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 769-778.
[12]	Wei Xiaorui, Yu Zeyang, Yang Kun, Zhou Ke, Huang Fang, Liu Hao, Bai Lu, Liu Jiayun. Expression of liver kinase B1 in peripheral blood mononuclear cells of Mycobacterium tuberculosis-infected individuals and its correlation with interferon-γ [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 779-784.
[13]	Li Wei, Zhou Zhichao, Zheng Jie. Trends and hotspots in multidrug-resistant tuberculosis research in China (1995—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 785-791.
[14]	Qi Qi, Wang Zihao, Ye Linlin, Peng Wenbei, Zhou Qiong. Immune checkpoint inhibitors and tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 792-797.
[15]	Senior Department of Tuberculosis, the 8th Medical Center of Chinese PLA General Hospital, Editorial Board of Chinese Journal of Antituberculosis, Basic and Clinical Speciality Committees of Tuberculosis Control Branch of China International Exchange and Promotive Association for Medical and Health Care. Expert consensus on the diagnosis and treatment of urological tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 546-558.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 11

Related Articles 15

Recommended Articles

Metrics

Comments